Folate-mediated one-carbon metabolism and neural tube defects: balancing genome synthesis and gene expression.

Neural tube defects (NTDs) refer to a cluster of neurodevelopmental conditions associated with failure of neural tube closure during embryonic development. Worldwide prevalence of NTDs ranges from approximately 0.5 to 60 per 10,000 births, with regional and population-specific variation in prevalence. Numerous environmental and genetic influences contribute to NTD etiology; accumulating evidence from population-based studies has demonstrated that folate status is a significant determinant of NTD risk. Folate-mediated one-carbon metabolism (OCM) is essential for de novo nucleotide biosynthesis, methionine biosynthesis, and cellular methylation reactions. Periconceptional maternal supplementation with folic acid can prevent occurrence of NTDs in the general population by up to 70%; currently several countries fortify their food supply with folic acid for the prevention of NTDs. Despite the unambiguous impact of folate status on NTD risk, the mechanism by which folic acid protects against NTDs remains unknown. Identification of the mechanism by which folate status affects neural tube closure will assist in developing more efficacious and better targeted preventative measures. In this review, we summarize current research on the relationship between folate status and NTDs, with an emphasis on linking genetic variation, folate nutriture, and specific metabolic and/or genomic pathways that intersect to determine NTD outcomes.

[1]  M. Levene,et al.  Altered folate metabolism and disposition in mothers affected by a spina bifida pregnancy: influence of 677c --> t methylenetetrahydrofolate reductase and 2756a --> g methionine synthase genotypes. , 2000, Molecular genetics and metabolism.

[2]  Quanhe Yang,et al.  5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. , 2000, American journal of epidemiology.

[3]  H. Blom,et al.  The methionine synthase reductase 66A>G polymorphism is a maternal risk factor for spina bifida , 2006, Journal of Molecular Medicine.

[4]  P. Stover,et al.  5-Formyltetrahydrofolate Regulates Homocysteine Remethylation in Human Neuroblastoma* , 1997, The Journal of Biological Chemistry.

[5]  R. Rozen,et al.  Evaluation of genetic variants in the reduced folate carrier and in glutamate carboxypeptidase II for spina bifida risk. , 2003, Molecular genetics and metabolism.

[6]  Richard G. W. Anderson,et al.  Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development , 1999, Nature Genetics.

[7]  Santhosh K. P. Kumar,et al.  Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[8]  D. Quilliot,et al.  The effect of 677C-->T and 1298A-->C mutations on plasma homocysteine and 5,10-methylenetetrahydrofolate reductase activity in healthy subjects. , 2000, The British journal of nutrition.

[9]  Katie A. Burren,et al.  Integrity of the methylation cycle is essential for mammalian neural tube closure. , 2006, Birth defects research. Part A, Clinical and molecular teratology.

[10]  J. Burn,et al.  Susceptibility to spina bifida; an association study of five candidate genes , 1998, Annals of human genetics.

[11]  G. Shaw,et al.  Are the betaine‐homocysteine methyltransferase (BHMT and BHMT2) genes risk factors for spina bifida and orofacial clefts? , 2005, American journal of medical genetics. Part A.

[12]  R. Waterland,et al.  Post-weaning diet affects genomic imprinting at the insulin-like growth factor 2 (Igf2) locus. , 2006, Human molecular genetics.

[13]  C. Croce,et al.  Knockdown of ALR (MLL2) Reveals ALR Target Genes and Leads to Alterations in Cell Adhesion and Growth , 2006, Molecular and Cellular Biology.

[14]  A. Copp,et al.  Embryonic folate metabolism and mouse neural tube defects. , 1998, Science.

[15]  M. Loeken,et al.  Hypoxic stress in diabetic pregnancy contributes to impaired embryo gene expression and defective development by inducing oxidative stress. , 2005, American journal of physiology. Endocrinology and metabolism.

[16]  J. Boucher,et al.  Homocysteine induces oxidative stress by uncoupling of NO synthase activity through reduction of tetrahydrobiopterin. , 2004, Free radical biology & medicine.

[17]  A. Clifford,et al.  Behavioral and neurochemical changes in folate-deficient mice , 1995, Physiology & Behavior.

[18]  P. Bosco,et al.  Transcobalamin and methionine synthase reductase mutated polymorphisms aggravate the risk of neural tube defects in humans , 2003, Neuroscience Letters.

[19]  J. Gilbert,et al.  Neural Tube Defects and Folate Pathway Genes: Family-Based Association Tests of Gene–Gene and Gene–Environment Interactions , 2006, Environmental health perspectives.

[20]  J. Mills,et al.  Neural tube defect rates before and after food fortification with folic acid. , 2004, Birth defects research. Part A, Clinical and molecular teratology.

[21]  S. J. James,et al.  Lack of embryotoxicity of homocysteine thiolactone in mouse embryos in vitro. , 2001, Reproductive toxicology.

[22]  R. Rozen,et al.  Effects of polymorphisms of methionine synthase and methionine synthase reductase on total plasma homocysteine in the NHLBI Family Heart Study. , 2003, Atherosclerosis.

[23]  B. Hibbard.  Defective Folate Metabolism in Pathological Conditions of Pregnancy , 1967, Acta obstetricia et gynecologica Scandinavica.

[24]  D. A. Jencks,et al.  Allosteric inhibition of methylenetetrahydrofolate reductase by adenosylmethionine. Effects of adenosylmethionine and NADPH on the equilibrium between active and inactive forms of the enzyme and on the kinetics of approach to equilibrium. , 1987, The Journal of biological chemistry.

[25]  V. Schirch,et al.  Interaction of folylpolyglutamates with enzymes in one-carbon metabolism. , 1989, Archives of biochemistry and biophysics.

[26]  M. Koch,et al.  Interaction of folate and homocysteine pathway genotypes evaluated in susceptibility to neural tube defects (NTD) in a German population , 2001, Journal of Human Genetics.

[27]  Keesook Lee,et al.  Srg3, a Mouse Homolog of Yeast SWI3, Is Essential for Early Embryogenesis and Involved in Brain Development , 2001, Molecular and Cellular Biology.

[28]  T. Marquardt,et al.  Linkage disequilibrium of the common mutations 677C > T and 1298A > C of the human methylenetetrahydrofolate reductase gene as proven by the novel polymorphisms 129C > T, 1068C > T , 2000, European Journal of Pediatrics.

[29]  D. Weir,et al.  PATHOGENESIS OF SUBACUTE COMBINED DEGENERATION: A RESULT OF METHYL GROUP DEFICIENCY , 1981, The Lancet.

[30]  K J Rothman,et al.  Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. , 1989, JAMA.

[31]  Y. Pao,et al.  Parallel changes in metabolite and expression profiles in crooked-tail mutant and folate-reduced wild-type mice. , 2006, Human molecular genetics.

[32]  C. Culmsee,et al.  Homocysteine Elicits a DNA Damage Response in Neurons That Promotes Apoptosis and Hypersensitivity to Excitotoxicity , 2000, The Journal of Neuroscience.

[33]  A. Bowron,et al.  The influence of genetic and environmental factors on plasma homocysteine concentrations in a population at high risk for coronary artery disease , 2005, Annals of clinical biochemistry.

[34]  Ali Shilatifard,et al.  Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression. , 2006, Annual review of biochemistry.

[35]  G. Shaw,et al.  Associations between polymorphisms within the thymidylate synthase gene and spina bifida. , 2003, Birth defects research. Part A, Clinical and molecular teratology.

[36]  K. Robert,et al.  Expression of the Cystathionine β Synthase (CBS) Gene During Mouse Development and Immunolocalization in Adult Brain , 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[37]  C. Relton,et al.  Thymidylate synthase repeat polymorphisms and risk of neural tube defects in a population from the northern United Kingdom. , 2004, Birth defects research. Part A, Clinical and molecular teratology.

[38]  R. Castro,et al.  5,10-Methylenetetrahydrofolate reductase 677C-->T and 1298A-->C mutations are genetic determinants of elevated homocysteine. , 2003, QJM : monthly journal of the Association of Physicians.

[39]  Elizabeth L. Barry,et al.  Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. , 2007, JAMA.

[40]  M. Loeken,et al.  Oxidant regulation of gene expression and neural tube development: Insights gained from diabetic pregnancy on molecular causes of neural tube defects , 2003, Diabetologia.

[41]  V. Ganapathy,et al.  Reduced-folate carrier (RFC) is expressed in placenta and yolk sac, as well as in cells of the developing forebrain, hindbrain, neural tube, craniofacial region, eye, limb buds and heart , 2003, BMC Developmental Biology.

[42]  M. McDonnell,et al.  Maternal genetic effects, exerted by genes involved in homocysteine remethylation, influence the risk of spina bifida. , 2002, American journal of human genetics.

[43]  M. Rudnicki,et al.  Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. , 2001, Human molecular genetics.

[44]  A. Czeizel,et al.  Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin Supplementation , 1992 .

[45]  P. Jagodziński,et al.  The role of mammalian DNA methyltransferases in the regulation of gene expression. , 2005, Cellular & molecular biology letters.

[46]  M. Ross,et al.  Crooked tail (Cd) model of human folate-responsive neural tube defects is mutated in Wnt coreceptor lipoprotein receptor-related protein 6. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[47]  L. Gentry,et al.  Differential stereospecificities and affinities of folate receptor isoforms for folate compounds and antifolates. , 1992, Biochemical pharmacology.

[48]  M. den Heyer,et al.  Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida , 1995, The Lancet.

[49]  H. Blom,et al.  Gene-gene interaction between the cystathionine beta-synthase 31 base pair variable number of tandem repeats and the methylenetetrahydrofolate reductase 677C > T polymorphism on homocysteine levels and risk for neural tube defects. , 2003, Molecular genetics and metabolism.

[50]  M. Pearce,et al.  Gene–gene interaction in folate-related genes and risk of neural tube defects in a UK population , 2004, Journal of Medical Genetics.

[51]  F. D’Anselmi,et al.  S-adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production , 2005, Molecular and Cellular Neuroscience.

[52]  R. Kodell,et al.  Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[53]  A. Herbig,et al.  New perspectives on folate catabolism. , 2003, Annual review of nutrition.

[54]  G. Shaw,et al.  Homocysteine remethylation enzyme polymorphisms and increased risks for neural tube defects. , 2003, Molecular genetics and metabolism.

[55]  J F Gregory,et al.  Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement. , 1999, The Journal of nutrition.

[56]  R. Matthews,et al.  Substrate flux through methylenetetrahydrofolate dehydrogenase: predicted effects of the concentration of methylenetetrahydrofolate on its partitioning into pathways leading to nucleotide biosynthesis or methionine regeneration. , 1988, Biochemistry.

[57]  K. Ghoshal,et al.  DNA Methyltransferase 3b Regulates Nerve Growth Factor-Induced Differentiation of PC12 Cells by Recruiting Histone Deacetylase 2 , 2005, Molecular and Cellular Biology.

[58]  W. Willett,et al.  Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. , 1997, Cancer research.

[59]  Y. Friedlander,et al.  A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations. , 1999, The Journal of nutrition.

[60]  G. Varela-Moreiras,et al.  Homocysteine modifies development of neurulation and dorsal root ganglia in chick embryos. , 2002, Teratology.

[61]  H. Blom,et al.  Genetic variation in genes of folate metabolism and neural-tube defect risk* , 2006, Proceedings of the Nutrition Society.

[62]  M. Spinella,et al.  Increased expression and characterization of two distinct folate binding proteins in murine erythroleukemia cells. , 1994, Biochemical pharmacology.

[63]  R. G. Anderson,et al.  Potocytosis: sequestration and transport of small molecules by caveolae. , 1992, Science.

[64]  Katie A. Burren,et al.  Excess methionine suppresses the methylation cycle and inhibits neural tube closure in mouse embryos , 2006, FEBS letters.

[65]  Brauer Pr,et al.  Consequences of elevated homocysteine during embryonic development and possible modes of action. , 2004 .

[66]  S. Zeisel,et al.  Perturbations in choline metabolism cause neural tube defects in mouse embryos in vitro , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[67]  R. Matthews,et al.  A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase , 1995, Nature Genetics.

[68]  E. Mariman,et al.  Decreased methylene tetrahydrofolate reductase activity due to the 677C→T mutation in families with spina bifida offspring , 1996, Journal of Molecular Medicine.

[69]  Album Ma.  A hazard of modern life. , 1983 .

[70]  William F. Morgan,et al.  Genomic instability in Gadd45a-deficient mice , 1999, Nature Genetics.

[71]  Maternal methylenetetrahydrofolate reductase deficiency and low dietary folate lead to adverse reproductive outcomes and congenital heart defects in mice , 2005 .

[72]  R. Finnell,et al.  Investigation of folate pathway gene polymorphisms and the incidence of neural tube defects in a Texas hispanic population. , 2000, Molecular genetics and metabolism.

[73]  H. Blom,et al.  Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. , 1995, American journal of human genetics.

[74]  F. Muller,et al.  Screening of the C677T mutation on the methylenetetrahydrofolate reductase gene in French patients with neural tube defects , 1997, Human Genetics.

[75]  T. Liu,et al.  Homocysteine thiolactone induces apoptotic DNA damage mediated by increased intracellular hydrogen peroxide and caspase 3 activation in HL-60 cells. , 2001, Life sciences.

[76]  M. Ross,et al.  Crooked tail (Cd) models human folate-responsive neural tube defects. , 1999, Human molecular genetics.

[77]  N. Horie,et al.  Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5'-terminal regulatory region of the human gene for thymidylate synthase. , 1995, Cell structure and function.

[78]  M. Seller,et al.  Periconceptional vitamin supplementation and the prevention of neural tube defects in south-east England and Northern Ireland. , 1984, Journal of medical genetics.

[79]  Gary M. Shaw,et al.  Neural tube defects and folate: case far from closed , 2006, Nature Reviews Neuroscience.

[80]  R. Surtees,et al.  Distal motor axonopathy and central nervous system myelin vacuolation caused by cycloleucine, an inhibitor of methionine adenosyltransferase. , 1992, Brain : a journal of neurology.

[81]  B. Wlodarczyk,et al.  Spontaneous neural tube defects in splotch mice supplemented with selected micronutrients. , 2006, Toxicology and applied pharmacology.

[82]  T. Chevassut,et al.  Severe Global DNA Hypomethylation Blocks Differentiation and Induces Histone Hyperacetylation in Embryonic Stem Cells , 2004, Molecular and Cellular Biology.

[83]  B. Shane.  FOLATE CHEMISTRY AND METABOLISM* , 2001 .

[84]  H. McNulty,et al.  Genetic and nutritional factors contributing to hyperhomocysteinemia in young adults. , 2003, Blood.

[85]  A. Parle‐McDermott,et al.  Analysis of methionine synthase reductase polymorphisms for neural tube defects risk association. , 2005, Molecular genetics and metabolism.

[86]  P. Kamoun,et al.  Spatial and temporal expression of the cystathionine beta-synthase gene during early human development. , 1999, Biochemical and biophysical research communications.

[87]  R. G. Vergel,et al.  Primary prevention of neural tube defects with folic acid supplementation: Cuban experience , 1990, Prenatal diagnosis.

[88]  H. Blom,et al.  Vitamin B12 insufficiency and the risk of fetal neural tube defects. , 2003, QJM : monthly journal of the Association of Physicians.

[89]  P. Stover,et al.  Evidence for Small Ubiquitin-like Modifier-dependent Nuclear Import of the Thymidylate Biosynthesis Pathway* , 2007, Journal of Biological Chemistry.

[90]  R. Rozen,et al.  Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects. , 1999, American journal of medical genetics.

[91]  H. Blom,et al.  A 31 bp VNTR in the cystathionine β-synthase (CBS) gene is associated with reduced CBS activity and elevated post-load homocysteine levels , 2001, European Journal of Human Genetics.

[92]  Megakaryocytic differentiation induced in 416B myeloid cells by GATA-2 and GATA-3 transgenes or 5-azacytidine is tightly coupled to GATA-1 expression. , 1993 .

[93]  P. Stover.  Physiology of folate and vitamin B12 in health and disease. , 2004, Nutrition reviews.

[94]  S. Hinrichs,et al.  Folate deficiency alone does not produce neural tube defects in mice. , 1992, The Journal of nutrition.

[95]  K. Christensen,et al.  Genotype frequencies and linkage disequilibrium in the CEPH human diversity panel for variants in folate pathway genes MTHFR, MTHFD, MTRR, RFC1, and GCP2. , 2003, Birth defects research. Part A, Clinical and molecular teratology.

[96]  A. Read,et al.  FURTHER EXPERIENCE OF VITAMIN SUPPLEMENTATION FOR PREVENTION OF NEURAL TUBE DEFECT RECURRENCES , 1983, The Lancet.

[97]  J. Yarnell,et al.  The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia. , 1996, QJM : monthly journal of the Association of Physicians.

[98]  F. Nieto,et al.  The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[99]  H. Blom,et al.  Is mutated serine hydroxymethyltransferase (SHMT) involved in the etiology of neural tube defects? , 2001, Molecular genetics and metabolism.

[100]  A. Copp.  Neurulation in the cranial region – normal and abnormal , 2005, Journal of anatomy.

[101]  M. Blasco,et al.  Telomere shortening in mTR−/− embryos is associated with failure to close the neural tube , 1999, The EMBO journal.

[102]  S. Buyske,et al.  New 19 bp deletion polymorphism in intron‐1 of dihydrofolate reductase (DHFR): A risk factor for spina bifida acting in mothers during pregnancy? , 2004, American journal of medical genetics. Part A.

[103]  Katherine L. Herbig,et al.  Cytoplasmic Serine Hydroxymethyltransferase Mediates Competition between Folate-dependent Deoxyribonucleotide andS-Adenosylmethionine Biosyntheses* , 2002, The Journal of Biological Chemistry.

[104]  I. Chang,et al.  Pyruvate inhibits zinc-mediated pancreatic islet cell death and diabetes , 2003, Diabetologia.

[105]  J. Selhub,et al.  Homocysteine induces congenital defects of the heart and neural tube: effect of folic acid. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[106]  H. McNulty,et al.  The thymidylate synthase tandem repeat polymorphism is not associated with homocysteine concentrations in healthy young subjects , 2003, Human Genetics.

[107]  E. Rampersaud,et al.  Updated investigations of the role of methylenetetrahydrofolate reductase in human neural tube defects , 2003, Clinical genetics.

[108]  B. Eray,et al.  Effects of a DNA demethylating agent--5-azacytidine--on testicular morphology during mouse embryo development. , 1999 .

[109]  A. G. Gittenberger-de Groot,et al.  Folic acid and homocysteine affect neural crest and neuroepithelial cell outgrowth and differentiation in vitro , 2003, Developmental dynamics : an official publication of the American Association of Anatomists.

[110]  J. Mills,et al.  Homocysteine metabolism in pregnancies complicated by neural-tube defects , 1995, The Lancet.

[111]  S. Sunden,et al.  Betaine-homocysteine methyltransferase expression in porcine and human tissues and chromosomal localization of the human gene. , 1997, Archives of biochemistry and biophysics.

[112]  R. Behringer,et al.  Prenatal folic acid treatment suppresses acrania and meroanencephaly in mice mutant for the Cart1 homeobox gene , 1996, Nature Genetics.

[113]  B. Shane.  Folylpolyglutamate synthesis and role in the regulation of one-carbon metabolism. , 1989, Vitamins and hormones.

[114]  A. Schousboe,et al.  Cytotoxic actions and effects on intracellular Ca2+ and cGMP concentrations of sulphur‐containing excitatory amino acids in cultured cerebral cortical neurons , 1993, Journal of neuroscience research.

[115]  Mitsuyoshi Nakao,et al.  Dynamic changes in the epigenomic state and nuclear organization of differentiating mouse embryonic stem cells , 2007, Genes to cells : devoted to molecular & cellular mechanisms.

[116]  G. Bennett,et al.  Failure of homocysteine to induce neural tube defects in a mouse model. , 2006, Birth defects research. Part B, Developmental and reproductive toxicology.

[117]  J. Mulinare.  Periconceptional Use of Multivitamins and the Occurrence of Neural Tube Defects , 1988 .

[118]  R. Finnell,et al.  Reduced folate carrier gene is a risk factor for neural tube defects in a Chinese population. , 2005, Birth defects research. Part A, Clinical and molecular teratology.

[119]  R. Finnell,et al.  Study of MTHFR and MS polymorphisms as risk factors for NTD in the Italian population , 2002, Journal of Human Genetics.

[120]  E. Merello,et al.  Evaluation of a methylenetetrahydrofolate-dehydrogenase 1958G>A polymorphism for neural tube defect risk , 2006, Journal of Human Genetics.

[121]  E. Melvin,et al.  Possible interaction of genotypes at cystathionine β‐synthase and methylenetetrahydrofolate reductase (MTHFR) in neural tube defects , 1999 .

[122]  M. Margaglione,et al.  Homocysteine metabolism in families from southern Italy with neural tube defects: role of genetic and nutritional determinants , 2006, Prenatal diagnosis.

[123]  C. Francannet,et al.  [International Clearinghouse for Birth Defects Monitoring Systems (ICBDMS). An example of effective international cooperation]. , 1986, Archives francaises de pediatrie.

[124]  H. Blom,et al.  Sequence analysis of the coding region of human methionine synthase: relevance to hyperhomocysteinaemia in neural-tube defects and vascular disease. , 1997, QJM : monthly journal of the Association of Physicians.

[125]  M. Stitzel,et al.  Targeted Disruption of the Methionine Synthase Gene in Mice , 2001, Molecular and Cellular Biology.

[126]  A. Parle‐McDermott,et al.  Analysis of the MTHFR 1298A→C and 677C→T polymorphisms as risk factors for neural tube defects , 2003, Journal of Human Genetics.

[127]  A. Chango,et al.  A polymorphism (80G->A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia. , 2000, Molecular genetics and metabolism.

[128]  J. Burn,et al.  Methylenetetrahydrofolate reductase and neural tube defects , 1996, The Lancet.

[129]  M. P. Sperandeo,et al.  The molecular basis of homocystinuria due to cystathionine beta-synthase deficiency in Italian families, and report of four novel mutations. , 1995, American journal of human genetics.

[130]  C Y Ou,et al.  5,10 Methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. , 1996, American journal of medical genetics.

[131]  E. Lein,et al.  Mice lacking methyl-CpG binding protein 1 have deficits in adult neurogenesis and hippocampal function , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[132]  R. Rozen,et al.  Polymorphisms in methionine synthase reductase and betaine-homocysteine S-methyltransferase genes: risk of placental abruption. , 2007, Molecular genetics and metabolism.

[133]  R. G. Anderson,et al.  Delivery of folates to the cytoplasm of MA104 cells is mediated by a surface membrane receptor that recycles. , 1988, The Journal of biological chemistry.

[134]  N. Greene,et al.  Homocysteine is embryotoxic but does not cause neural tube defects in mouse embryos , 2003, Anatomy and Embryology.

[135]  M. Tulliez,et al.  Plasma homocysteine levels related to interactions between folate status and methylenetetrahydrofolate reductase: a study in 52 healthy subjects. , 1998, Metabolism: clinical and experimental.

[136]  C. Garza,et al.  Bringing individuality to public health recommendations. , 2002, The Journal of nutrition.

[137]  K. Shiota,et al.  Spatial and temporal expression of folate‐binding protein 1 (Fbp1) is closely associated with anterior neural tube closure in mice , 2002, Developmental dynamics : an official publication of the American Association of Anatomists.

[138]  W. Edelmann,et al.  Rescue of Embryonic Lethality in Reduced Folate Carrier-deficient Mice by Maternal Folic Acid Supplementation Reveals Early Neonatal Failure of Hematopoietic Organs* , 2001, The Journal of Biological Chemistry.

[139]  C. Deng,et al.  Genetic Interactions between Brca1 and Gadd45a in Centrosome Duplication, Genetic Stability, and Neural Tube Closure* , 2004, Journal of Biological Chemistry.

[140]  A. Ziegler,et al.  Linkage disequilibrium of MTHFR genotypes 677C/T-1298A/C in the German population and association studies in probands with neural tube defects(NTD). , 1999, American journal of medical genetics.

[141]  C. Schorah,et al.  Vitamin dificiencies and neural tube defects. , 1976, Archives of disease in childhood.

[142]  R. Rozen,et al.  Investigations of a common genetic variant in betaine-homocysteine methyltransferase (BHMT) in coronary artery disease. , 2003, Atherosclerosis.

[143]  K. Binks,et al.  Low erythrocyte folate status and polymorphic variation in folate-related genes are associated with risk of neural tube defect pregnancy. , 2004, Molecular genetics and metabolism.

[144]  J. Mathers,et al.  Folate and DNA methylation during in utero development and aging. , 2004, Biochemical Society transactions.

[145]  J. Mills,et al.  Low blood folates in NTD pregnancies are only partly explained by thermolabile 5,10-methylenetetrahydrofolate reductase: low folate status alone may be the critical factor. , 1998, American journal of medical genetics.

[146]  H. Blom,et al.  Is the common 677C-->T mutation in the methylenetetrahydrofolate reductase gene a risk factor for neural tube defects? A meta-analysis. , 1997, QJM : monthly journal of the Association of Physicians.

[147]  B. Epe,et al.  Incorporation of dUMP into DNA is a major source of spontaneous DNA damage, while excision of uracil is not required for cytotoxicity of fluoropyrimidines in mouse embryonic fibroblasts. , 2004, Carcinogenesis.

[148]  A. Parle‐McDermott,et al.  Analysis of the human folate receptor beta gene for an association with neural tube defects. , 2003, Molecular genetics and metabolism.

[149]  H. Knapp,et al.  Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans. , 1999, Circulation.

[150]  B. Shane,et al.  Expression of Escherichia coli folylpolyglutamate synthetase in the Chinese hamster ovary cell mitochondrion. , 1994, The Journal of biological chemistry.

[151]  H. Ved,et al.  Correlation between inhibition of myelin basic protein (arginine) methyltransferase by sinefungoin and lack of compact myelin formation in cultures of cerebral cells from embryonic mice , 1986, Journal of neuroscience research.

[152]  M. Akabas,et al.  Identification of an Intestinal Folate Transporter and the Molecular Basis for Hereditary Folate Malabsorption , 2006, Cell.

[153]  J. Oxford,et al.  Suppression of MeCP2beta expression inhibits neurite extension in PC12 cells. , 2004, Experimental cell research.

[154]  D. Shields,et al.  The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. , 1999, American journal of human genetics.

[155]  A. Parle‐McDermott,et al.  A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: report of the Birth Defects Research Group. , 2002, American journal of human genetics.

[156]  F. Stanley,et al.  Dietary folate as a risk factor for neural‐tube defects: evidence from a case‐control study in Western Australia , 1989, The Medical journal of Australia.

[157]  G. Shaw,et al.  Lack of association between mutations in the folate receptor-α gene and spina bifida , 1998 .

[158]  G. Watanabe,et al.  Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[159]  A. Parle‐McDermott,et al.  Confirmation of the R653Q polymorphism of the trifunctional C1-synthase enzyme as a maternal risk for neural tube defects in the Irish population , 2006, European Journal of Human Genetics.

[160]  D C Shields,et al.  A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. , 1995, QJM : monthly journal of the Association of Physicians.

[161]  P. Brauer,et al.  Homocysteine inhibits cardiac neural crest cell formation and morphogenesis in vivo , 2004, Developmental dynamics : an official publication of the American Association of Anatomists.

[162]  J. Troendle,et al.  The 19‐bp deletion polymorphism in intron‐1 of dihydrofolate reductase (DHFR) may decrease rather than increase risk for spina bifida in the Irish population , 2007, American journal of medical genetics. Part A.

[163]  A. Simeone,et al.  Folic acid prevents exencephaly in Cited2 deficient mice. , 2002, Human molecular genetics.

[164]  I. Delgado-Enciso,et al.  Folate levels and N(5),N(10)-methylenetetrahydrofolate reductase genotype (MTHFR) in mothers of offspring with neural tube defects: a case-control study. , 2001, Archives of medical research.

[165]  J. Selhub,et al.  Investigation of the effects of folate deficiency on embryonic development through the establishment of a folate deficient mouse model. , 2002, Teratology.

[166]  T. Shea,et al.  Multiple aspects of homocysteine neurotoxicity: Glutamate excitotoxicity, kinase hyperactivation and DNA damage , 2002, Journal of neuroscience research.

[167]  D G Wilkinson,et al.  Control of cell behavior during vertebrate development by Slug, a zinc finger gene. , 1994, Science.

[168]  B. Ames,et al.  Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[169]  E. Stokstad,et al.  Mammalian methylenetetrahydrofolate reductase. Partial purification, properties, and inhibition by S-adenosylmethionine. , 1971, Biochimica et biophysica acta.

[170]  D. Hunter,et al.  Linkage disequilibrium between the 677C>T and 1298A>C polymorphisms in human methylenetetrahydrofolate reductase gene and their contributions to risk of colorectal cancer. , 2002, Pharmacogenetics.

[171]  K. Shelnutt,et al.  Methylenetetrahydrofolate reductase 677C->T polymorphism and folate status affect one-carbon incorporation into human DNA deoxynucleosides. , 2005, The Journal of nutrition.

[172]  Simpson Ca.  OYSTER AND VIRUS. , 1964 .

[173]  D. Marion,et al.  S-Adenosylmethionine and S-adenosylhomocystein metabolism in isolated rat liver. Effects of L-methionine, L-homocystein, and adenosine. , 1980, The Journal of biological chemistry.

[174]  R. Rozen,et al.  Common variant in betaine‐homocysteine methyltransferase (BHMT) and risk for spina bifida , 2003, American journal of medical genetics. Part A.

[175]  R. J. Mullen,et al.  Altered cell proliferation in the spinal cord of mouse neural tube mutants curly tail and Pax3 splotch-delayed. , 1997, Brain research. Developmental brain research.

[176]  D. Appling.  Compartmentation of folate‐mediated one‐carbon metabolism in eukaryotes , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[177]  S. Mudd.  Disorders of transsulfuration , 1989 .

[178]  Prevention of neural tube defects: Results of the Medical Research Council vitamin study , 1991 .

[179]  R. Rozen,et al.  A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. , 1998, Molecular genetics and metabolism.

[180]  M. Namihira,et al.  Developmental stage dependent regulation of DNA methylation and chromatin modification in a immature astrocyte specific gene promoter , 2004, FEBS letters.

[181]  N. Hanson,et al.  Variable number tandem repeat in exon/intron border of the cystathionine beta-synthase gene: a single nucleotide substitution in the second repeat prevents multiple alternate splicing. , 2000, American journal of medical genetics.

[182]  B. Franke,et al.  Variation and expression of dihydrofolate reductase (DHFR) in relation to spina bifida. , 2007, Molecular genetics and metabolism.

[183]  B. Ames,et al.  Folate Deficiency Inhibits the Proliferation of Primary Human CD8+ T Lymphocytes In Vitro1 , 2004, The Journal of Immunology.

[184]  H. Teraoka,et al.  Multiple species of mammalian S-adenosylmethionine synthetase. Partial purification and characterization. , 1981, Biochemistry.

[185]  N. Maeda,et al.  Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[186]  Katie A. Burren,et al.  Abnormal folate metabolism in foetuses affected by neural tube defects. , 2006, Brain : a journal of neurology.

[187]  S. S. Kang,et al.  Thermolabile methylenetetrahydrofolate reductase in patients with coronary artery disease. , 1988, Metabolism: clinical and experimental.

[188]  G. Shaw,et al.  PERICONCEPTIONAL VITAMIN USE, DIETARY FOLATE, AND THE OCCURRENCE OF NEURAL TUBE DEFECTS , 1995, Epidemiology.

[189]  J. Finkelstein,et al.  The metabolism of homocysteine: pathways and regulation , 1998, European Journal of Pediatrics.

[190]  C. Ulrich,et al.  Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. , 2006, The Journal of nutrition.

[191]  I. Rosenberg,et al.  Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. , 1996, Circulation.

[192]  M. Ferguson-Smith,et al.  Is disordered folate metabolism the basis for the genetic predisposition to neural tube defects? , 1987, Clinical genetics.

[193]  G. Coetzee,et al.  Thymidylate synthase: a novel genetic determinant of plasma homocysteine and folate levels , 2002, Human Genetics.

[194]  E. Stokstad,et al.  The Availability of Food Folate in Man , 1973, Nutrition reviews.

[195]  R. Matthews,et al.  Metabolic derangement of methionine and folate metabolism in mice deficient in methionine synthase reductase. , 2007, Molecular genetics and metabolism.

[196]  B. Hibbard.  THE ROLE OF FOLIC ACID IN PREGNANCY * , 1964, The Journal of obstetrics and gynaecology of the British Commonwealth.

[197]  M. J. Harris,et al.  Mouse models for neural tube closure defects. , 2000, Human molecular genetics.

[198]  J. Loscalzo,et al.  Cellular Redox State and Endothelial Dysfunction in Mildly Hyperhomocysteinemic Cystathionine &bgr;‐Synthase‐Deficient Mice , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[199]  G. Shaw,et al.  Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida. , 2002, American journal of medical genetics.

[200]  G. Boers,et al.  Neural-tube defects and derangement of homocysteine metabolism. , 1991, The New England journal of medicine.

[201]  E. Mariman,et al.  Methionine synthase and neural tube defects. , 1997, Journal of medical genetics.

[202]  G. Shaw,et al.  Evaluation of infant methylenetetrahydrofolate reductase genotype, maternal vitamin use, and risk of high versus low level spina bifida defects. , 2003, Birth defects research. Part A, Clinical and molecular teratology.

[203]  P. Gluckman,et al.  Epigenetic regulation of human trophoblastic cell migration and invasion. , 2006, Endocrinology.